Azimuth Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.58M | Sell |
2,670
-10
| -0.4% | -$5.91K | 0.07% | 205 |
|
|
2021
Q4 | $1.79M | Sell |
2,680
-35
| -1% | -$23.4K | 0.07% | 204 |
|
|
2021
Q3 | $1.55M | Sell |
2,715
-3
| -0.1% | -$1.71K | 0.07% | 204 |
|
|
2021
Q2 | $1.37M | Buy |
2,718
+8
| +0.3% | +$4.04K | 0.06% | 218 |
|
|
2021
Q1 | $1.24M | Buy |
2,710
+475
| +21% | +$217K | 0.06% | 222 |
|
|
2020
Q4 | $1.04M | Hold |
2,235
| – | – | 0.05% | 220 |
|
|
2020
Q3 | $987K | Sell |
2,235
-267
| -11% | -$118K | 0.06% | 204 |
|
|
2020
Q2 | $907K | Sell |
2,502
-33
| -1% | -$12K | 0.06% | 206 |
|
|
2020
Q1 | $719K | Sell |
2,535
-61
| -2% | -$17.3K | 0.05% | 214 |
|
|
2019
Q4 | $843K | Sell |
2,596
-300
| -10% | -$97.4K | 0.05% | 212 |
|
|
2019
Q3 | $844K | Sell |
2,896
-95
| -3% | -$27.7K | 0.06% | 210 |
|
|
2019
Q2 | $878K | Sell |
2,991
-25
| -0.8% | -$7.34K | 0.06% | 209 |
|
|
2019
Q1 | $826K | Buy |
3,016
+320
| +12% | +$87.6K | 0.06% | 216 |
|
|
2018
Q4 | $603K | Sell |
2,696
-219
| -8% | -$49K | 0.05% | 223 |
|
|
2018
Q3 | $711K | Hold |
2,915
| – | – | 0.05% | 218 |
|
|
2018
Q2 | $604K | Hold |
2,915
| – | – | 0.04% | 221 |
|
|
2018
Q1 | $602K | Sell |
2,915
-5
| -0.2% | -$1.03K | 0.04% | 221 |
|
|
2017
Q4 | $554K | Sell |
2,920
-250
| -8% | -$47.4K | 0.04% | 227 |
|
|
2017
Q3 | $600K | Hold |
3,170
| – | – | 0.04% | 223 |
|
|
2017
Q2 | $553K | Sell |
3,170
-40
| -1% | -$6.98K | 0.04% | 228 |
|
|
2017
Q1 | $493K | Buy |
3,210
+25
| +0.8% | +$3.84K | 0.04% | 232 |
|
|
2016
Q4 | $449K | Buy |
3,185
+435
| +16% | +$61.3K | 0.04% | 234 |
|
|
2016
Q3 | $437K | Hold |
2,750
| – | – | 0.04% | 232 |
|
|
2016
Q2 | $406K | Buy |
+2,750
| New | +$406K | 0.04% | 236 |
|